Types/leukemia/patient/cll-treatment-pdq

Kuvura indwara ya Lymphocytike ya Leukemia idakira (®) - Indwara y'abarwayi

Amakuru Rusange Yerekeye Indwara ya Lymphocytike idakira

INGINGO Z'INGENZI

• Indwara ya lymphocytike idakira ni ubwoko bwa kanseri aho igufwa ryo mu magufa rikora lymphocytes nyinshi (ubwoko bw'amaraso yera).

• Leukemia irashobora kwanduza selile zitukura, selile yera, na platine.

• Ubusaza bushobora kugira ingaruka zo kurwara lymphocytike idakira.

• Ibimenyetso nibimenyetso bya lymphocytike leukemia idakira harimo kubyimba lymph node no kunanirwa.

• Ibizamini bisuzuma amaraso, amagufwa, na lymph node bikoreshwa mugupima indwara ya lymphocytike idakira.

• Ibintu bimwe bigira ingaruka kumahitamo no kuvura (amahirwe yo gukira).

Indwara ya lymphocytike idakira ni ubwoko bwa kanseri aho igufwa ryo mu magufa rikora lymphocytes nyinshi (ubwoko bw'amaraso yera).

Indwara ya lymphocytike idakira (nanone yitwa CLL) n'indwara y'amaraso n'amagufwa bikunze kwiyongera buhoro buhoro. CLL ni bumwe mu bwoko bwa leukemia ikunze kugaragara ku bantu bakuru. Bikunze kubaho mugihe cyangwa nyuma yimyaka yo hagati; ni gake cyane mu bana.

Anatomy yamagufwa. Igufwa rigizwe n'amagufwa magufi, amagufwa ya spongy, n'amagufwa. Amagufwa magufi agize igice cyinyuma cyamagufwa. Amagufwa ya spongy aboneka cyane kumpera yamagufa kandi arimo umusemburo utukura. Amagufwa yo mu magufa aboneka hagati yamagufwa menshi kandi afite imiyoboro myinshi yamaraso. Hariho ubwoko bubiri bwamagufwa: umutuku numuhondo. Umutuku utukura urimo ingirangingo z'amaraso zishobora guhinduka selile zitukura, selile yera, cyangwa platine. Umuhondo wumuhondo ugizwe ahanini namavuta.

Leukemia irashobora kwanduza selile zitukura, selile yera, na platine. Mubisanzwe, umubiri ukora ingirangingo zamaraso (selile zidakuze) zihinduka ingirabuzimafatizo zikuze mugihe runaka. Ingirabuzimafatizo y'amaraso irashobora guhinduka myeloid stem selile cyangwa lymphoide stem selile.

Ingirabuzimafatizo ya myeloid ihinduka bumwe mu bwoko butatu bw'amaraso akuze:

• Uturemangingo twamaraso dutukura dutwara ogisijeni nibindi bintu mubice byose byumubiri.

• Utugingo ngengabuzima twera turwanya indwara n'indwara.

• Amashanyarazi akora amaraso kugirango areke kuva amaraso.

Lymphoide stem selile ihinduka lymphoblast selile hanyuma bumwe mubwoko butatu bwa lymphocytes (selile yera):

• B lymphocytes B ikora antibodies zifasha kurwanya kwandura.

• Lymphocytes T ifasha lymphocytes B gukora antibodies zo kurwanya indwara.

• Ingirabuzimafatizo zica zitera kanseri na virusi.

Gukura kw'amaraso. Ingirabuzimafatizo y'amaraso inyura mu ntambwe nyinshi kugirango ihinduke selile itukura, platine, cyangwa selile yera.

Muri CLL, ingirangingo nyinshi zamaraso zihinduka lymphocytes zidasanzwe kandi ntizibe selile yera yera. Lymphocytes idasanzwe irashobora kandi kwitwa selile leukemia. Lymphocytes ntishobora kurwanya kwandura neza. Nanone, uko umubare wa lymphocytes wiyongera mu maraso no mu magufa, nta mwanya muto w’uturemangingo twiza tw’amaraso yera, selile zitukura, na platine. Ibi birashobora gutera kwandura, kubura amaraso, no kuva amaraso byoroshye.

Iyi ncamake ivuga kubyerekeye lymphocytike idakira. Reba incamake ya ikurikira kubindi bisobanuro bijyanye na leukemia:

• Abakuze Bavura Lymphoblastique Leukemia.

• Ubwana bwo kuvura Lymphoblastique Leukemia.

• Abakuze Acute Myeloid Leukemia.

• Ubwana Bukaze Myeloid Leukemia / Ubundi buryo bwo kuvura indwara ya Myeloid.

• Umuti wa karande Myelogenous Leukemia.

• Umuti wimitsi ya leukemia.

Ubusaza bushobora kugira ingaruka zo kurwara lymphocytike idakira.

Ikintu cyose cyongera ibyago byo kwandura byitwa impanuka. Kugira ibintu bishobora guteza ibyago ntibisobanura ko uzarwara kanseri; kutagira ibyago bishobora gusobanura ko utazarwara kanseri. Vugana na muganga wawe niba utekereza ko ushobora guhura n'akaga. Impamvu zishobora gutera CLL zirimo ibi bikurikira:

• Kuba ufite imyaka yo hagati cyangwa mukuru, umugabo, cyangwa umweru.

• Amateka yumuryango ya CLL cyangwa kanseri ya sisitemu ya lymph.

• Kugira bene wabo ari Abayahudi b'Abarusiya cyangwa Abayahudi bo mu Burayi bw'i Burasirazuba.

Ibimenyetso nibimenyetso bya lymphocytike leukemia idakira harimo kubyimba lymph node no kunanirwa.

Mubisanzwe CLL ntabwo itera ibimenyetso cyangwa ibimenyetso kandi iboneka mugihe cyo kwisuzumisha bisanzwe. Ibimenyetso nibimenyetso bishobora guterwa na CLL cyangwa nibindi bihe. Menyesha umuganga wawe niba ufite kimwe muri ibi bikurikira:

• Kubabara kutagira ububabare bwa lymph node mu ijosi, munsi yintoki, igifu, cyangwa igituba.

• Kumva unaniwe cyane.

• Kubabara cyangwa kuzura munsi y'urubavu.

• Umuriro n'indwara.

• Kugabanya ibiro nta mpamvu izwi.

Ibizamini bisuzuma amaraso, amagufwa, na lymph node bikoreshwa mugupima indwara ya lymphocytike idakira.

Ibizamini hamwe nuburyo bukurikira birashobora gukoreshwa:

• Ikizamini cyumubiri namateka yubuzima: Ikizamini cyumubiri kugirango ugenzure ibimenyetso rusange byubuzima, harimo no gusuzuma ibimenyetso byindwara, nkibibyimba cyangwa ikindi kintu cyose gisa nkidasanzwe. Hazafatwa kandi amateka yubuzima bwumurwayi nindwara zashize hamwe nubuvuzi.

• Umubare wuzuye wamaraso (CBC) ufite itandukaniro: Uburyo bwo gukuramo urugero rwamaraso no gusuzuma ibi bikurikira:

• Umubare w'uturemangingo tw'amaraso atukura na platine.

• Umubare nubwoko bwingirangingo zamaraso yera.

• Ingano ya hemoglobine (proteyine itwara ogisijeni) mu ngirangingo z'amaraso atukura.

• Igice cyicyitegererezo cyamaraso kigizwe ningirabuzimafatizo zitukura.

Kubara amaraso yuzuye (CBC). Amaraso akusanywa no kwinjiza inshinge mumitsi no kwemerera amaraso gutembera mumiyoboro. Icyitegererezo cyamaraso cyoherezwa muri laboratoire hanyuma selile zitukura, selile yera, na platine zirabaze. CBC ikoreshwa mugupima, gusuzuma, no gukurikirana ibintu byinshi bitandukanye.

• Immunophenotyping: Ikizamini cya laboratoire ikoresha antibodies kugirango hamenyekane kanseri ya kanseri ukurikije ubwoko bwa antigene cyangwa ibimenyetso hejuru ya selile. Iki kizamini gikoreshwa mugufasha gusuzuma ubwoko bwihariye bwa leukemia.

• AMAFI (fluorescence in situ hybridisation): Ikizamini cya laboratoire ikoreshwa mu kureba no kubara gen cyangwa chromosomes mu ngirabuzimafatizo no mu ngingo. Ibice bya ADN birimo amarangi ya fluorescent bikozwe muri laboratoire hanyuma bikongerwaho icyitegererezo cy'uturemangingo cyangwa ingirangingo z'umurwayi. Iyo ibyo bice bisize irangi bya ADN bifatanye na gen cyangwa uduce twa chromosomes murugero, biramurika iyo urebye munsi ya microscope ya fluorescent. Ikizamini cy'Amafi gikoreshwa mu gufasha gusuzuma kanseri no gufasha kuvura.

• Flow cytometry: Ikizamini cya laboratoire gipima umubare w'utugingo ngengabuzima, ijanisha ry'utugingo ngengabuzima turi mu cyitegererezo, hamwe n'ibiranga ingirabuzimafatizo, nk'ubunini, imiterere, hamwe n'ibimenyetso by'ibibyimba (cyangwa ibindi) kuri Ubuso. Ingirabuzimafatizo ziva mu cyitegererezo cy'amaraso y'umurwayi, igufwa ry'amagufa, cyangwa izindi ngingo zandujwe irangi rya fluorescent, zishyirwa mu mazi, hanyuma zikanyura rimwe na rimwe binyuze mu rumuri. Ibisubizo by'ibizamini bishingiye ku kuntu ingirabuzimafatizo zandujwe irangi rya fluorescent zifata urumuri. Iki kizamini gikoreshwa mugufasha gusuzuma no gucunga ubwoko bumwe na bumwe bwa kanseri, nka leukemia na lymphoma.

• Ikizamini cya mutation ya IgVH: Ikizamini cya laboratoire gipimwa urugero rwamaraso cyangwa tissue kugirango habeho impinduka zimwe na zimwe muri gen IgVH. Abarwayi bafite ihindagurika rya gene ya IgVH bafite prognoza nziza.

• Amagufa ya marrow aspiration na biopsy: Gukuraho igufwa ryamagufa, amaraso, nigice gito cyamagufwa winjiza urushinge rudafite epfo na ruguru cyangwa amabere. Inzobere mu by'indwara ireba amagufwa, amaraso, n'amagufwa munsi ya microscope kugirango ishakishe ingirabuzimafatizo zidasanzwe.

Amagufa ya marrow icyifuzo na biopsy. Nyuma yuko agace gato k'uruhu kamaze kunanirwa, urushinge rw'amagufwa rwinjizwa mu igufwa ry'umurwayi. Ingero z'amaraso, amagufwa, n'amagufwa byavanyweho kugirango bisuzumwe kuri microscope.

Ibintu bimwe bigira ingaruka kumahitamo no kuvura (amahirwe yo gukira).

Uburyo bwo kuvura buterwa na:

• Intambwe yindwara.

• Uturemangingo twamaraso dutukura, selile yera, hamwe namaraso ya platel.

vIbyo hari ibimenyetso cyangwa ibimenyetso, nk'umuriro, gukonja, cyangwa kugabanya ibiro.

• Niba umwijima, ururenda, cyangwa lymph node ari nini kuruta ibisanzwe.

• Igisubizo kubuvuzi bwambere.

• Niba CLL yagarutse (garuka).

Kumenyekanisha biterwa na:

• Niba hari impinduka muri ADN n'ubwoko bw'impinduka, niba hari imwe.

• Niba lymphocytes ikwirakwira mu magufa.

• Intambwe yindwara.

• Niba CLL igenda neza hamwe no kuvurwa cyangwa yagarutse (garuka).

• Niba CLL itera imbere kuri lymphoma cyangwa leukemia ya prolymphocytike.

• Imyaka yumurwayi nubuzima rusange.

Ibyiciro bya Lymphocytic Leukemia

INGINGO Z'INGENZI

• Nyuma yo gupimwa indwara ya lymphocytike idakira, hakozwe ibizamini kugirango hamenyekane intera kanseri imaze gukwirakwira mu maraso no mu magufa.

• Ibyiciro bikurikira bikoreshwa kuri lymphocytike idakira:

• Icyiciro 0

• Icyiciro I.

• Icyiciro cya II

• Icyiciro cya III

• Icyiciro cya IV

Nyuma yo gupimwa indwara ya lymphocytike idakira, hakozwe ibizamini kugirango hamenyekane intera kanseri imaze gukwirakwira mu maraso no mu magufa.

Gutegura ni inzira ikoreshwa mu kumenya intera kanseri imaze gukwirakwira. Ni ngombwa kumenya icyiciro cyindwara kugirango utegure uburyo bwiza bwo kuvura. Ibizamini bikurikira birashobora gukoreshwa mugutegura:

• Isanduku x-ray: X-ray yingingo namagufwa imbere yigituza. X-ray ni ubwoko bwingufu zishobora kunyura mumubiri no kuri firime, bigakora ishusho yibice biri mumubiri, nka lymph node.

• MRI . Ubu buryo bwitwa kandi magnetic magnetic resonance imaging (NMRI).

• CT scan (CAT scan): Uburyo bukora urukurikirane rwamashusho arambuye yibice byimbere mumubiri, byafashwe muburyo butandukanye. Amashusho yakozwe na mudasobwa ihujwe na mashini ya x-ray. Irangi rishobora guterwa mumitsi cyangwa kumirwa kugirango bifashe ingingo cyangwa ingirangingo kugaragara neza. Ubu buryo nabwo bwitwa computing tomografiya, tomografiya ya mudasobwa, cyangwa mudasobwa ya axial tomografiya.

• PET-CT scan: Uburyo bukomatanya amashusho kuva positron yoherejwe na tomografiya (PET) scan hamwe na tomografi yabazwe (CT) scan. Gusikana PET na CT bikorwa icyarimwe hamwe nimashini imwe. Gusikana hamwe bitanga amashusho arambuye yibice byimbere mumubiri kuruta scan itanga yonyine. PET scan nuburyo bwo gushakisha ingirabuzimafatizo mbi mu mubiri. Umubare muto wa glucose ikora radio (isukari) yatewe mumitsi. PET scaneri izenguruka umubiri kandi ikora ishusho yerekana aho glucose ikoreshwa mumubiri. Utugingo ngengabuzima twibibyimba twerekana neza cyane ku ishusho kuko zikora cyane kandi zifata glucose nyinshi kuruta selile zisanzwe.

• Ubushakashatsi bwa chimie yamaraso: Uburyo bwo gusuzuma urugero rwamaraso kugirango bapime urugero rwibintu bimwe na bimwe bisohoka mumaraso ningingo nuduce twumubiri. Umubare udasanzwe (uri hejuru cyangwa uri munsi yubusanzwe) ibintu bishobora kuba ikimenyetso cyindwara.

• Ikizamini cya Antiglobuline: Ikizamini kireba icyitegererezo cyamaraso munsi ya microscope kugirango hamenyekane niba hari antibodies ziri hejuru yuturemangingo twamaraso dutukura cyangwa platine. Izi antibodies zirashobora kubyitwaramo no gusenya selile zitukura zamaraso na platine. Iki kizamini nacyo cyitwa Coombs test.

Ibyiciro bikurikira bikoreshwa kuri lymphocytike idakira:

Icyiciro 0

Mu cyiciro cya 0 lymphocytike leukemia idakira, hariho lymphocytes nyinshi mu maraso, ariko nta bindi bimenyetso cyangwa ibimenyetso bya leukemia. Icyiciro 0 lymphocytike leukemia idakira ni indone (gukura-buhoro).

Icyiciro I.

Mu cyiciro cya I lymphocytike leukemia idakira, hariho lymphocytes nyinshi mumaraso kandi lymph node nini kuruta izisanzwe.

Icyiciro cya II

Mu cyiciro cya II lymphocytike leukemia idakira, hariho lymphocytes nyinshi mu maraso, umwijima cyangwa ururenda ni binini kuruta ibisanzwe, kandi lymph node irashobora kuba nini kuruta ibisanzwe.

Icyiciro cya III

Mu cyiciro cya III lymphocytike leukemia idakira, hariho lymphocytes nyinshi mu maraso kandi hari selile nkeya zitukura. Indimu ya lymph, umwijima, cyangwa ururenda birashobora kuba binini kuruta ibisanzwe.

Icyiciro cya IV

Mu cyiciro cya IV lymphocytike leukemia idakira, hariho lymphocytes nyinshi mumaraso hamwe na platine nkeya. Indimu ya lymph, umwijima, cyangwa ururenda birashobora kuba binini kuruta ibisanzwe kandi hashobora kubaho selile nkeya zitukura.

Indwara ya Lymphocytike idakira cyangwa yisubiraho

Indwara ya lymphocytike idakira ni kanseri yagarutse (garuka), ubusanzwe nyuma yigihe runaka kanseri idashobora kumenyekana. Indwara ya lymphocytike idakira ni kanseri idakira neza hamwe no kuvurwa.

Incamake yo kuvura

INGINGO Z'INGENZI

• Hariho uburyo butandukanye bwo kuvura abarwayi bafite lymphocytike idakira.

• Ubwoko butanu bwo kuvura busanzwe bukoreshwa:

• Gutegereza neza

• Imiti ivura imirasire
• Chimoterapi

• Kubaga

• Ubuvuzi bugamije

• Ubwoko bushya bwo kuvura burimo kugeragezwa mubigeragezo byamavuriro.

• Chimoterapi hamwe no guhinduranya ingirangingo

• Immunotherapy

• Umuti wa lymphocytike leukemia idakira urashobora gutera ingaruka mbi.

• Abarwayi barashobora kwifuza gutekereza kubijyanye no kwipimisha kwa muganga.

• Abarwayi barashobora kwipimisha kwa muganga mbere, mugihe, cyangwa nyuma yo gutangira kuvura kanseri.

• Ibizamini byo gukurikirana birashobora gukenerwa.

Hariho uburyo butandukanye bwo kuvura abarwayi bafite lymphocytike idakira.

Ubwoko butandukanye bwo kuvura burahari kubarwayi barwaye lymphocytike idakira. Bumwe mu buryo busanzwe (ubuvuzi bukoreshwa ubu), kandi bumwe burimo kugeragezwa mubigeragezo byamavuriro. Ikigeragezo kivura ni ubushakashatsi bwakozwe bugamije gufasha kunoza imiti igezweho cyangwa kubona amakuru ku buvuzi bushya ku barwayi ba kanseri. Iyo ibizamini byo kwa muganga byerekana ko ubuvuzi bushya buruta ubuvuzi busanzwe, ubuvuzi bushya bushobora kuba ubuvuzi busanzwe. Abarwayi barashobora kwifuza gutekereza kubijyanye no kwipimisha kwa muganga. Ibigeragezo bimwe na bimwe bivura abarwayi batatangiye kwivuza.

Ubwoko butanu bwo kuvura busanzwe bukoreshwa:

Gutegereza neza

Gutegereza witonze ni ugukurikiranira hafi uko umurwayi ameze atabanje kwivuza kugeza ibimenyetso cyangwa ibimenyetso bigaragara cyangwa bihindutse. Ibi byitwa kandi kwitegereza. Muri iki gihe, ibibazo biterwa n'indwara, nk'ubwandu, biravurwa.

Imishwarara ivura Imirasire ni imiti ivura kanseri ikoresha ingufu nyinshi za x-imirasire cyangwa ubundi bwoko bwimirasire yica kanseri cyangwa ikabuza gukura. Imiti ivura hanze ikoresha imashini hanze yumubiri kugirango yohereze imirasire yerekeza kumubiri hamwe na kanseri.

Imiti ivura hanze ikoreshwa mu kuvura indwara ya lymphocytike idakira.

Chimoterapi

Chimoterapi ni umuti wa kanseri ukoresha ibiyobyabwenge kugirango uhagarike imikurire ya kanseri, haba mu kwica selile cyangwa kubabuza gutandukana. Iyo chimiotherapie ifashwe numunwa cyangwa igaterwa mumitsi cyangwa imitsi, imiti yinjira mumaraso kandi irashobora kugera kanseri ya kanseri mumubiri (chimiotherapie sisitemu). Iyo chimiotherapie ishyizwe mumazi ya cerebrospinal fluid, urugingo, cyangwa umwobo wumubiri nkinda, cyangwa imiti yibasira kanseri ya kanseri muri utwo turere (chimiotherapie yo mukarere). Uburyo chimiotherapie itangwa biterwa nubwoko nicyiciro cya kanseri ivurwa.

Reba Ibiyobyabwenge Byemewe kuri Lymphocytike Leukemia idakira kubindi bisobanuro.

Kubaga

Splenectomy ni kubaga kugirango bakureho intanga.

Ubuvuzi bugamije

Ubuvuzi bugamije ni uburyo bwo kuvura bukoresha ibiyobyabwenge cyangwa ibindi bintu kugirango umenye kandi utere kanseri yihariye ya kanseri utangiza ingirabuzimafatizo zisanzwe. Ubuvuzi bwa antibody ya Monoclonal, tyrosine kinase inhibitor therapy, hamwe nubuvuzi bwa BCL2 ni ubwoko bwubuvuzi bugamije gukoreshwa mu kuvura indwara ya lymphocytike idakira.

Ubuvuzi bwa Tyrosine kinase inhibitor nubuvuzi bwa kanseri buhagarika ibimenyetso bikenewe kugirango ibibyimba bikure.

Ubuvuzi bwa BCL2 ni imiti ivura kanseri ibuza poroteyine yitwa BCL2. Ubuvuzi bwa BCL2 bushobora kwica kanseri kandi birashobora gutuma bumva neza indi miti igabanya ubukana.

Reba Ibiyobyabwenge Byemewe kuri Lymphocytike Leukemia idakira kubindi bisobanuro.

Ubwoko bushya bwo kuvura burimo kugeragezwa mubigeragezo byamavuriro.

Iki gice cyincamake gisobanura imiti irimo kwigwa mubigeragezo byamavuriro. Ntishobora kuvuga ubuvuzi bushya burimo kwigwa. Amakuru yerekeye ibizamini byamavuriro araboneka kurubuga rwa NCI.

Chimoterapi hamwe no guhinduranya ingirangingo

Chimoterapi hamwe no guhinduranya ingirangingo ni uburyo bwo gutanga chimiotherapie no gusimbuza selile zikora amaraso zangijwe no kuvura kanseri. Ingirabuzimafatizo (selile zidakuze) zivanwa mumaraso cyangwa igufwa ryumurwayi cyangwa umuterankunga hanyuma bikonjeshwa bikabikwa. Nyuma ya chimiotherapie irangiye, ingirangingo zibitswe zabitswe hanyuma zisubizwa umurwayi binyuze mu gushiramo. Izi ngirabuzimafatizo zongeye gukoreshwa zikura (kandi zigarura) ingirangingo z'amaraso z'umubiri.

Immunotherapy

Immunotherapy nubuvuzi bukoresha sisitemu yumubiri yumurwayi kurwanya kanseri. Ibintu bikozwe numubiri cyangwa bikozwe muri laboratoire bikoreshwa mukuzamura, kuyobora, cyangwa kugarura umubiri kamere irinda kanseri. Ubu bwoko bwo kuvura kanseri nabwo bwitwa biotherapy cyangwa biologique therapy.

CAR T-selile ivura ni ubwoko bwa immunotherapie ihindura selile ya T yumurwayi (ubwoko bwimikorere yumubiri) kuburyo bazatera proteine ​​zimwe na zimwe hejuru ya selile kanseri. T selile yakuwe kumurwayi kandi reseptor zidasanzwe zongerwa hejuru yazo muri laboratoire. Ingirabuzimafatizo zahinduwe zitwa chimeric antigen reseptor (CAR) T. Ingirabuzimafatizo za CAR T zikurira muri laboratoire ziha umurwayi infusion. Ingirabuzimafatizo za CAR T zigwira mu maraso y’umurwayi kandi zigatera kanseri. Ubuvuzi bwa CAR T-selile burimo kwigwa mukuvura indwara ya lymphocytike idakira.

CAR T-selile. Ubwoko bwo kuvura aho selile ya T yumurwayi (ubwoko bwimikorere yumubiri) ihindurwa muri laboratoire kugirango ihuze ingirangingo za kanseri ikabica. Amaraso ava mumitsi mumaboko yumurwayi anyura mumiyoboro yerekeza mumashini ya aperesi (iterekanwa), ikuraho selile yera, harimo na selile T, kandi igasubiza amaraso asigaye kumurwayi. Hanyuma, gene ya reseptor idasanzwe yitwa chimeric antigen reseptor (CAR) yinjizwa muri selile T muri laboratoire. Amamiriyoni ya selile CAR T akura muri laboratoire hanyuma agahabwa umurwayi yatewe. Ingirabuzimafatizo za CAR T zishobora guhuza antigen kuri selile ya kanseri ikabica.

Umuti wa lymphocytike leukemia idakira urashobora gutera ingaruka mbi.

Kumakuru yingaruka ziterwa no kuvura kanseri, reba urupapuro rwuruhande rwacu.

Abarwayi barashobora kwifuza gutekereza kubijyanye no kwipimisha kwa muganga.

Ku barwayi bamwe, kwitabira ikizamini cyamavuriro birashobora kuba uburyo bwiza bwo kuvura. Ibigeragezo bivura biri mubikorwa byubushakashatsi bwa kanseri. Igeragezwa rya Clinical rikorwa kugirango hamenyekane niba imiti mishya ya kanseri itekanye kandi ifite akamaro cyangwa nziza kuruta ubuvuzi busanzwe.

Benshi mubuvuzi busanzwe bwa kanseri bushingiye kubigeragezo byambere byubuvuzi. Abarwayi bitabiriye kwipimisha barashobora kuvurwa bisanzwe cyangwa kuba mubambere bahawe imiti mishya.

Abarwayi bitabira ibizamini byo kwa muganga nabo bafasha kunoza uburyo kanseri izavurwa mugihe kizaza. Nubwo ibigeragezo bivura bitaganisha ku buvuzi bushya, akenshi basubiza ibibazo byingenzi kandi bigafasha gutera imbere ubushakashatsi.

Abarwayi barashobora kwipimisha kwa muganga mbere, mugihe, cyangwa nyuma yo gutangira kuvura kanseri.

Igeragezwa rimwe na rimwe ririmo abarwayi bataravurwa. Ibindi bigeragezo bipima abarwayi bafite kanseri itameze neza. Hariho kandi ibizamini byo kwa muganga bipima uburyo bushya bwo guhagarika kanseri kongera kugaruka (kugaruka) cyangwa kugabanya ingaruka zo kuvura kanseri.

Igeragezwa rya Clinical ririmo kubera mu bice byinshi by'igihugu. Amakuru yerekeye ibizamini byamavuriro ashyigikiwe na NCI urashobora kubisanga kurubuga rwa NCI. Ibizamini bya Clinical bishyigikiwe nandi mashyirahamwe murashobora kubisanga kurubuga rwa ClinicalTrials.gov.

Ibizamini byo gukurikirana birashobora gukenerwa.

Bimwe mubizamini byakozwe mugupima kanseri cyangwa kumenya icyiciro cya kanseri birashobora gusubirwamo. Ibizamini bimwe bizasubirwamo kugirango harebwe uburyo ubuvuzi bukora neza. Ibyemezo bijyanye no gukomeza, guhindura, cyangwa guhagarika ubuvuzi birashobora gushingira kubisubizo byibi bizamini.

Bimwe mubizamini bizakomeza gukorwa buri gihe nyuma yubuvuzi burangiye. Ibisubizo by'ibi bizamini birashobora kwerekana niba ubuzima bwawe bwarahindutse cyangwa niba kanseri yarongeye (garuka). Ibi bizamini rimwe na rimwe byitwa gukurikirana-ibizamini cyangwa kugenzura.

Amahitamo yo Kuvura Icyiciro

Muri iki gice

• Icyiciro 0 Indwara ya Lymphocytike idakira

• Icyiciro cya I, Icyiciro cya II, Icyiciro cya III, na Icyiciro cya IV Indwara ya Lymphocytike idakira

Kumakuru yerekeye imiti yavuzwe hepfo, reba igice cyo kuvura.

Icyiciro 0 Indwara ya Lymphocytike idakira

Kuvura icyiciro 0 lymphocytike leukemia idakira mubisanzwe itegereje.

Koresha ubushakashatsi bwamavuriro kugirango ushakishe NCI ifashwa na kanseri ivura abarwayi. Urashobora gushakisha ibigeragezo ukurikije ubwoko bwa kanseri, imyaka yumurwayi, n’aho ibizamini bikorerwa. Amakuru rusange yerekeye ibizamini byamavuriro nayo arahari.

Icyiciro cya I, Icyiciro cya II, Icyiciro cya III, na Icyiciro cya IV Indwara ya Lymphocytike idakira

Kuvura icyiciro cya I, icyiciro cya II, icyiciro cya III, nicyiciro cya IV lymphocytike leukemia idakira irashobora kubamo ibi bikurikira:

• Gutegereza witonze mugihe hari ibimenyetso cyangwa ibimenyetso bike cyangwa bidafite ibimenyetso.

• Ubuvuzi bugamije hamwe na antibody ya monoclonal, inhibitor ya tyrosine kinase, cyangwa inhibitor ya BCL2.

• Chimiotherapie hamwe nibiyobyabwenge 1 cyangwa byinshi, hamwe na steroyide cyangwa idafite antibody ya monoclonal.

• Umuti muke wo kuvura imishwarara yo hanze mubice byumubiri aho kanseri iboneka, nkururenda cyangwa lymph node.

• Igeragezwa rya chimiotherapie hamwe nubuvuzi bwibinyabuzima hamwe no guterwa ingirangingo.

• Ikigeragezo cyamavuriro yubuvuzi bushya.

Koresha ubushakashatsi bwamavuriro kugirango ushakishe NCI ifashwa na kanseri ivura abarwayi. Urashobora gushakisha ibigeragezo ukurikije ubwoko bwa kanseri, imyaka yumurwayi, n’aho ibizamini bikorerwa. Amakuru rusange yerekeye ibizamini byamavuriro nayo arahari.

Amahitamo yo Kuvura Lymphocytike Yisubiramo cyangwa Yisubiramo

Leukemia

Kuvura indwara ya lymphocytike idakira isubirwamo cyangwa yangiritse irashobora kuba ikubiyemo bumwe mu buryo bwo kuvura bwasobanuwe haruguru cyangwa kwiyandikisha mu igeragezwa ry’ubuvuzi bushya. Reba Icyiciro cya I, Icyiciro cya II, Icyiciro cya III, na Icyiciro cya IV Indwara ya Lymphocytike ya Leukemiya idakira kugira ngo umenye amakuru menshi.

Koresha ubushakashatsi bwamavuriro kugirango ushakishe NCI ifashwa na kanseri ivura abarwayi. Urashobora gushakisha ibigeragezo ukurikije ubwoko bwa kanseri, imyaka yumurwayi, n’aho ibizamini bikorerwa. Amakuru rusange yerekeye ibizamini byamavuriro nayo arahari.

Kugira ngo umenye byinshi kuri Lymphocytike Leukemia idakira

Ushaka amakuru menshi yikigo cyigihugu cya kanseri kubyerekeye lymphocytike leukemia idakira, reba ibi bikurikira:

• Urupapuro rwa Leukemia

• Ibiyobyabwenge Byemewe kuri Lymphocytic Leukemia idakira

• Intego zo kuvura Kanseri

• Immunotherapy yo kuvura Kanseri

Kumakuru rusange ya kanseri nibindi bikoresho biva mu kigo cyigihugu cya kanseri, reba ibi bikurikira:

• Ibyerekeye Kanseri

• Gutegura

• Chimiotherapie nawe: Inkunga kubantu barwaye Kanseri

• Ubuvuzi bwimirasire nawe: Inkunga kubantu barwaye Kanseri

• Guhangana na Kanseri

• Ibibazo byo Kubaza Muganga wawe kuri Kanseri

• Abacitse ku icumu n'abarezi